Abstract
BackgroundT-cell immunoglobulin and ITIM domain (TIGIT) is identified as a novel checkpoint receptor that can facilitate immune escape via mediating T-cell exhaustion in tumors. However, the clinical significance and immune...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have